Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer

✍ Scribed by Verschraegen, C. F.; Czok, S.; Muller, C. Y.; Boyd, L.; Lee, S. J.; Rutledge, T.; Blank, S.; Pothuri, B.; Eberhardt, S.; Muggia, F.

• Book ID: 115521935
• Publisher: Oxford University Press
• Year: 2012
• Tongue: English
• Weight: 144 KB
• Volume: 23
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mds172